Basic Info
  • Grade: pharmaceutical grade

    Factory Location: Shanghai

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Malic acid cabozantinib is the malate form of cabozantinib, which is an orally bioavailable small molecule receptor tyrosine kinase (RTK) inhibitor with potential anti-tumor activity. Cabozantinib strongly binds and inhibits several RTKs, which are typically overexpressed in various cancer cell types, including hepatocyte growth factor receptor (MET), RET (rearrangement during transfection), vascular endothelial growth factor receptor type 1 (VEGFR-1), type 2 (VEGFR-2), and type 3 (VEGFR-3), mast/stem cell growth factor (KIT), FMS like tyrosine kinase 3 (FLT-3), TIE-2 (TEK tyrosine kinase, endothelial), tropomyosin associated kinase B (TRKB), and AXL. This may lead to inhibition of tumor growth and angiogenesis, ultimately leading to tumor regression.
Send your message to this supplier
  • From:
  • To:
    Shanghai Hope-chem Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service